It's just saliva.
No blood. No needles.
Our home-based saliva collection kit is all you need to send your DNA to the lab. We have made the process as simple as possible.Shop now
Three steps. It's simple.
All from home. No blood. No needles. Just a small saliva sample.
Choose from our Health plus Ancestry, Ancestry Service, or 23andMeplus Membership services. Your saliva collection kit is the same for both services and typically ships within 1 to 2 business days. Express shipping is available.
Follow kit instructions to spit in the tube provided — all from home. Register your saliva collection tube using the barcode so we know it belongs to you, and mail it back to our lab in the pre-paid package.
Your reports will be ready in about 3-4 weeks on average. We will send you an email to let you know your reports are ready in your online account. Log in and start discovering what your DNA says about you.
See how to get
Backed by science.
Our rigorous quality standards:
- Our Genetic Health Risk*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks, Carrier Status*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks , and Pharmacogenetics**Learn about Considerations and Limitations for Pharmacogenetics Reports reports meet criteria for being scientifically
and clinically valid and accurate
- All saliva samples are processed in CLIA-certified and CAP-accredited labs
- Our DNA collection kit is FDA-cleared for use with our Genetic Health Risk, Carrier Status, and Pharmacogenetics reports
- Genotyping is a well-established and reliable platform for analyzing DNA
- Our scientists and medical experts use a rigorous process to develop the reports to ensure validity
- Your personalized reports are based on well-established scientific and medical research
- Ancestry percentages are derived from our powerful, well-tested system that provides you with ancestry estimates down to the 0.1%
Hi. Still have questions about how it works?
Here are just a few of the things people frequently ask about 23andMe.
If you don't see your question here, get in touch with us.
23andMe offers three services: Ancestry Service, Health plus Ancestry Service and 23andMeplus Membership. All services require submitting a saliva sample using our saliva collection kit that you send to the lab for analysis.
Our Ancestry Service helps you understand who you are, where your DNA comes from and your family story. We analyze, compile and distill your DNA information into reports on your Ancestry Composition, Ancestry Detail Reports, Maternal & Paternal Haplogroups, Neanderthal Ancestry and provide a DNA Relatives tool to enable you to connect with relatives who share similar DNA.
Our Health plus Ancestry Service provides insights on your health predispositions*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks, carrier status*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks, traits, wellness and ancestry. We analyze, compile and distill the information extracted from your DNA into 150+ reports you can access online and share with family and friends.
Additionally, our 23andMeplus Membership is an annual membership and includes everything from our Health plus Ancestry Service plus access to exclusive reports and features that can help you learn more about your heart health, how you process certain medications**Learn about Considerations and Limitations for Pharmacogenetics Reports, likelihood for having migraine, and more. You’ll also receive enhanced ancestry features. Together, these 23andMe reports and features provide a more in-depth dive into your health and ancestry.
Our service is exclusively online. You'll receive your reports through a password-protected account at 23andme.com, and you'll have access to additional web-based tools and features.
In order to receive reports and participate in the service, you need to have a valid email address that allows you to send and receive messages. You also need access to a computer or mobile device that connects to the Internet.
You need to register your kit in order to link it to your 23andMe account online. Registration connects the barcode on your saliva sample to your account so we know your sample belongs to you. Our lab cannot process your sample if it is not registered.
Your saliva contains DNA from cells in your mouth. We send you a saliva collection kit and instructions for providing your sample.
Our CLIA-certified lab extracts DNA from cells in your saliva sample. Then the lab processes the DNA on a genotyping chip that reads hundreds of thousands of locations in your genome.
Your genetic data is analyzed, and we generate your personalized reports based on well-established scientific and medical research.
*The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/
**23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Our SLCO1B1 Pharmacogenetics report provides certain information about variants associated with the processing of some therapeutics and provides interpretive drug information regarding the potential effect of simvastatin therapy. Our DPYD Pharmacogenetics report does not describe the association between detected variants and any specific therapeutic. Results for DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For important information and limitations regarding Pharmacogenetic reports, visit 23andme.com/test-info/pharmacogenetics/